Corporate Banner
Satellite Banner
Technology Networks Header
Wednesday, July 30, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Dolomite Expertise Brings Microfluidic Product to Market
Monday, June 24, 2013
Fledgling spin-out company Drop-Tech has turned to microfluidics specialist Dolomite for its product development and fabrication skills.

Fluxion Delivers First Commercial Shipments of IsoFlux™ System
Friday, June 07, 2013
Platform enables pharma, research, and diagnostic companies to utilize blood samples for cancer diagnostic breakthroughs.

Dolomite Expertise Brings Microfluidic Product to Market
Friday, May 17, 2013
Mitos Dropix - Dolomite's new droplet-on-demand system.

A*STAR and Veredus Announces Launch of VereTrop™
Friday, April 26, 2013
First lab-on-chip for the detection of multiple tropical infectious diseases.

Dolomite Introduces Next Generation of Microfluidic Connectors and Interfaces
Wednesday, April 24, 2013
Offering high density and outstanding alignment for multiway fluidic connections.

Flow Reactor Delivers Highly Reproducible Bromination
Friday, March 22, 2013
Offers excellent control of both temperature and mixing using a proprietary mixer chip.

Unique Handheld Diagnostic Device - First of its Type in the Marketplace
Monday, March 18, 2013
AgPlus Diagnostics unveils the first working prototype of their unique new handheld system for rapid, on-the-spot diagnostic results.

Gyros AB Launches New Website
Tuesday, March 05, 2013
Features enhanced content and new downloadable support material.

Micronit Gives Permanent Price Reductions on their Catalogue Products
Tuesday, March 05, 2013
Company is reducing the prices with price cuts of up to 75%.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 1043
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv
Go to Lab-on-a-Chip RSS Feed